Selected research
Market Structure
Global Topical Corticosteroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Topical Corticosteroids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Topical Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Topical Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Topical Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Corticosteroids include Sanofi S.A., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Zylera Pharmaceuticals, Sandoz AG (Novartis AG), Bausch Health, AstraZeneca plc and Almirall, S.A, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Topical Corticosteroids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Topical Corticosteroids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Topical Corticosteroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Corticosteroids market size, projected growth trends, production technologies, key applications, and end-use industries.
Topical Corticosteroids Segment by Company
Sanofi S.A.
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc
Zylera Pharmaceuticals
Sandoz AG (Novartis AG)
Bausch Health
AstraZeneca plc
Almirall, S.A
Actimis Pharmaceuticals
Topical Corticosteroids Segment by Type
Class III
Class II
Class IV
Class I
Class VII
Class VI
Class V
Topical Corticosteroids Segment by Application
Hospitals
Pharmacies
Dermatology Clinics
Others
Topical Corticosteroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Corticosteroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Corticosteroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Corticosteroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Topical Corticosteroids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Corticosteroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Topical Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Topical Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Class III
- Class II
- Class IV
- Class I
- Class VII
- Class VI
- Class V
Applications
- Hospitals
- Pharmacies
- Dermatology Clinics
- Others
Companies covered
- Sanofi S.A.
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Zylera Pharmaceuticals
- Sandoz AG (Novartis AG)
- Bausch Health
- AstraZeneca plc
- Almirall, S.A
- Actimis Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Topical Corticosteroids Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Topical Corticosteroids Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Topical Corticosteroids Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Topical Corticosteroids Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Topical Corticosteroids Market Dynamics
- 2.1 Topical Corticosteroids Industry Trends
- 2.2 Topical Corticosteroids Industry Drivers
- 2.3 Topical Corticosteroids Industry Opportunities and Challenges
- 2.4 Topical Corticosteroids Industry Restraints
3 Topical Corticosteroids Market by Manufacturers
- 3.1 Global Topical Corticosteroids Revenue by Manufacturers (2021-2026)
- 3.2 Global Topical Corticosteroids Sales by Manufacturers (2021-2026)
- 3.3 Global Topical Corticosteroids Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Topical Corticosteroids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Corticosteroids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Topical Corticosteroids Manufacturers, Product Type & Application
- 3.7 Global Topical Corticosteroids Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Topical Corticosteroids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Topical Corticosteroids Players Market Share by Revenue in 2025
- 3.8.3 2025 Topical Corticosteroids Tier 1, Tier 2, and Tier 3
4 Topical Corticosteroids Market by Type
- 4.1 Topical Corticosteroids Type Introduction
- 4.1.1 Class III
- 4.1.2 Class II
- 4.1.3 Class IV
- 4.1.4 Class I
- 4.1.5 Class VII
- 4.1.6 Class VI
- 4.1.7 Class V
- 4.2 Global Topical Corticosteroids Sales by Type
- 4.2.1 Global Topical Corticosteroids Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Topical Corticosteroids Sales by Type (2021-2032)
- 4.2.3 Global Topical Corticosteroids Sales Market Share by Type (2021-2032)
- 4.3 Global Topical Corticosteroids Revenue by Type
- 4.3.1 Global Topical Corticosteroids Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Topical Corticosteroids Revenue by Type (2021-2032)
- 4.3.3 Global Topical Corticosteroids Revenue Market Share by Type (2021-2032)
5 Topical Corticosteroids Market by Application
- 5.1 Topical Corticosteroids Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Pharmacies
- 5.1.3 Dermatology Clinics
- 5.1.4 Others
- 5.2 Global Topical Corticosteroids Sales by Application
- 5.2.1 Global Topical Corticosteroids Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Topical Corticosteroids Sales by Application (2021-2032)
- 5.2.3 Global Topical Corticosteroids Sales Market Share by Application (2021-2032)
- 5.3 Global Topical Corticosteroids Revenue by Application
- 5.3.1 Global Topical Corticosteroids Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Topical Corticosteroids Revenue by Application (2021-2032)
- 5.3.3 Global Topical Corticosteroids Revenue Market Share by Application (2021-2032)
6 Global Topical Corticosteroids Sales by Region
- 6.1 Global Topical Corticosteroids Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Topical Corticosteroids Sales by Region (2021-2032)
- 6.2.1 Global Topical Corticosteroids Sales by Region (2021-2026)
- 6.2.2 Global Topical Corticosteroids Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Topical Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Topical Corticosteroids Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Topical Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Topical Corticosteroids Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Topical Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Topical Corticosteroids Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Topical Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Topical Corticosteroids Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Topical Corticosteroids Revenue by Region
- 7.1 Global Topical Corticosteroids Revenue by Region
- 7.1.1 Global Topical Corticosteroids Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Topical Corticosteroids Revenue by Region (2021-2026)
- 7.1.3 Global Topical Corticosteroids Revenue by Region (2027-2032)
- 7.1.4 Global Topical Corticosteroids Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Topical Corticosteroids Revenue (2021-2032)
- 7.2.2 North America Topical Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Topical Corticosteroids Revenue (2021-2032)
- 7.3.2 Europe Topical Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Topical Corticosteroids Revenue (2021-2032)
- 7.4.2 Asia-Pacific Topical Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Topical Corticosteroids Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Topical Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi S.A.
- 8.1.1 Sanofi S.A. Company Information
- 8.1.2 Sanofi S.A. Business Overview
- 8.1.3 Sanofi S.A. Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi S.A. Topical Corticosteroids Product Portfolio
- 8.1.5 Sanofi S.A. Recent Developments
- 8.2 Merck & Co., Inc.
- 8.2.1 Merck & Co., Inc. Company Information
- 8.2.2 Merck & Co., Inc. Business Overview
- 8.2.3 Merck & Co., Inc. Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck & Co., Inc. Topical Corticosteroids Product Portfolio
- 8.2.5 Merck & Co., Inc. Recent Developments
- 8.3 Pfizer Inc.
- 8.3.1 Pfizer Inc. Company Information
- 8.3.2 Pfizer Inc. Business Overview
- 8.3.3 Pfizer Inc. Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Inc. Topical Corticosteroids Product Portfolio
- 8.3.5 Pfizer Inc. Recent Developments
- 8.4 GlaxoSmithKline plc
- 8.4.1 GlaxoSmithKline plc Company Information
- 8.4.2 GlaxoSmithKline plc Business Overview
- 8.4.3 GlaxoSmithKline plc Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline plc Topical Corticosteroids Product Portfolio
- 8.4.5 GlaxoSmithKline plc Recent Developments
- 8.5 Zylera Pharmaceuticals
- 8.5.1 Zylera Pharmaceuticals Company Information
- 8.5.2 Zylera Pharmaceuticals Business Overview
- 8.5.3 Zylera Pharmaceuticals Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zylera Pharmaceuticals Topical Corticosteroids Product Portfolio
- 8.5.5 Zylera Pharmaceuticals Recent Developments
- 8.6 Sandoz AG (Novartis AG)
- 8.6.1 Sandoz AG (Novartis AG) Company Information
- 8.6.2 Sandoz AG (Novartis AG) Business Overview
- 8.6.3 Sandoz AG (Novartis AG) Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sandoz AG (Novartis AG) Topical Corticosteroids Product Portfolio
- 8.6.5 Sandoz AG (Novartis AG) Recent Developments
- 8.7 Bausch Health
- 8.7.1 Bausch Health Company Information
- 8.7.2 Bausch Health Business Overview
- 8.7.3 Bausch Health Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bausch Health Topical Corticosteroids Product Portfolio
- 8.7.5 Bausch Health Recent Developments
- 8.8 AstraZeneca plc
- 8.8.1 AstraZeneca plc Company Information
- 8.8.2 AstraZeneca plc Business Overview
- 8.8.3 AstraZeneca plc Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AstraZeneca plc Topical Corticosteroids Product Portfolio
- 8.8.5 AstraZeneca plc Recent Developments
- 8.9 Almirall, S.A
- 8.9.1 Almirall, S.A Company Information
- 8.9.2 Almirall, S.A Business Overview
- 8.9.3 Almirall, S.A Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Almirall, S.A Topical Corticosteroids Product Portfolio
- 8.9.5 Almirall, S.A Recent Developments
- 8.10 Actimis Pharmaceuticals
- 8.10.1 Actimis Pharmaceuticals Company Information
- 8.10.2 Actimis Pharmaceuticals Business Overview
- 8.10.3 Actimis Pharmaceuticals Topical Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Actimis Pharmaceuticals Topical Corticosteroids Product Portfolio
- 8.10.5 Actimis Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Topical Corticosteroids Value Chain Analysis
- 9.1.1 Topical Corticosteroids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Topical Corticosteroids Production Mode & Process
- 9.2 Topical Corticosteroids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Topical Corticosteroids Distributors
- 9.2.3 Topical Corticosteroids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst